Privia Health to Participate in the William Blair Growth Stock Conference
Rhea-AI Summary
On May 30, 2024, Privia Health Group (Nasdaq: PRVA) announced its participation in the 44th Annual William Blair Growth Stock Conference.
The presentation by the management team is scheduled for June 5, 2024, at 11:00 am ET / 10:00 am CT.
The live webcast and replay will be accessible on Privia Health's investor relations website.
Positive
- Participation in a high-profile conference can increase visibility and attract potential investors.
- Scheduled presentation by management team indicates proactive engagement with the investment community.
Negative
- No specific financial or clinical updates were provided in the announcement.
- The PR lacks detailed information on how this participation might translate to financial gains or business development.
News Market Reaction – PRVA
In the trading session that priced this news, PRVA gained 5.24%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT.
The live webcast and replay of the event will be available at ir.priviahealth.com/news-and-events/events-and-presentations.
About Privia Health
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health’s platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers. For more information, visit priviahealth.com.
Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841
